Post-adjuvant chemotherapy in ctDNA-positive patients with resected colorectal cancer: a randomized phase 3 trial

Journal:

Nature Medicine

Published:

2026-06-08

DOI:

10.1038/s41591-026-04428-0

Affiliations:

25

Authors:

34

Go to article

Institutions	Authors	Share
National Cancer Center Hospital East, Japan	6.500000	0.19
Natera, United States of America (USA)	6.000000	0.18
National Hospital Organization Osaka National Hospital, Japan	2.000000	0.06
National Taiwan University Hospital (NTUH), Taiwan	2.000000	0.06
EPS Corporation, Japan	2.000000	0.06
Sano Hospital, Japan	1.000000	0.03
Tokai National Higher Education and Research System (THERS), Japan	1.000000	0.03
Kyushu University Hospital, Japan	1.000000	0.03
Hokkaido University Hospital, Japan	1.000000	0.03
Kanagawa Cancer Center, Japan	1.000000	0.03
University of Occupational and Environmental Health (UOEH), Japan	1.000000	0.03
Kumamoto University, Japan	1.000000	0.03
Tohoku University Hospital, Japan	1.000000	0.03
Shizuoka Cancer Center, Japan	1.000000	0.03
Kyoto Katsura Hospital, Japan	1.000000	0.03
Shimane Prefectural Central Hospital, Japan	1.000000	0.03
Osaka Keisatsu Hospital, Japan	1.000000	0.03
Mayo Clinic, United States of America (USA)	1.000000	0.03
Aichi Cancer Center Hospital, Japan	1.000000	0.03
Kansai Medical University (KMU), Japan	0.500000	0.01
Yokohama City University Medical Center, YCU, Japan	0.500000	0.01
University of Oxford, United Kingdom (UK)	0.500000	0.01